NCT03883867

Brief Summary

The mechanical demands placed on the pelvic floor structures during vaginal delivery often exceed physiological tissue limits, resulting in maternal childbirth trauma, considerable postpartum morbidity, and increased risk of pelvic floor disorders(PFD). Injury to the perineum, vaginal supportive tissues, and pelvic floor muscles cause pain, infection, and dyspareunia, as well as pelvic organ prolapse(POP).Pregnancy and vaginal delivery are considered as a main risk factors in weakening the pelvic floor support and development of SUI, AI, and POP. CS is not only available countermeasure to reduce occurrence of obstetric trauma. Tactile imaging allows acquisition of 3D stress-strain data and 3D elasticity imaging or soft tissues.

Trial Health

90
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
20

participants targeted

Target at below P25 for all trials

Timeline
Completed

Started Mar 2019

Shorter than P25 for all trials

Geographic Reach
2 countries

3 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

March 8, 2019

Completed
11 days until next milestone

First Submitted

Initial submission to the registry

March 19, 2019

Completed
2 days until next milestone

First Posted

Study publicly available on registry

March 21, 2019

Completed
10 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 10, 2020

Completed
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

February 25, 2020

Completed
Last Updated

April 13, 2020

Status Verified

April 1, 2020

Enrollment Period

10 months

First QC Date

March 19, 2019

Last Update Submit

April 9, 2020

Conditions

Keywords

Pelvic Floor, Perineal Rapture, Obstetric Trauma

Outcome Measures

Primary Outcomes (2)

  • Prineum elasticity

    Measurement in units of elasticity, Young's modulus, kPa

    During examination procedure

  • Distance between pubic bone and perineum at 20 kPa load

    Measurement in unit of distance, mm

    During examination procedure

Study Arms (2)

Normal

The subject population will involve 10 non-pregnant women. The tactile imaging reprifucibility sub-group will include 5 non-pregnant subjects with 2 tactile imaging examinations completed in one session. All other subjects will have a single tactile imaging examination.

Pregnant

The subject population will involve 10 pregnant women without known complications at 36-37 weeks of pregnancy scheduled for a regular examination. All pregnant subjects should be examined weekly after completing 36th week of an uncomplicated pregnancy. Routine gynecologic examination includes external and internal obstetrical examination.

Eligibility Criteria

Age21 Years+
Sexfemale(Gender-based eligibility)
Gender Eligibility Detailswomen in reproductive age
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

The subject population will include 20 subjects. First group involves 10 non-pregnant women 5 of them will have 2 tactile imaging examinations completed in one session 5 others will have single tactile imaging examination. Second group involves 10 pregnant women without known complications at 36-37 weeks of pregnancy scheduled for a regular examination. All pregnant subjects should be examined weekly after completing 36 week of an uncomplicated pregnancy.

You may qualify if:

  • Non-pregnant women (Princeton Urogynecology, Princeton, NJ)
  • Pregnant women after completed 35th week of pregnancy with fetus in vertex position and premise of vaginal delivery (Division of Maternal-Fetal Medicine, Rutgers Robert Wood Johnson Medical School, New Brunswick, NJ)

You may not qualify if:

  • Prior perineal surgery
  • HIV or hepatitis B positive serology
  • Warty lesions on the vulva
  • Extensive varicose veins on the vulva
  • Aactive skin infection or ulceration within the vagina/vulva
  • Presence of vaginal septum
  • Severe hemorrhoids
  • Stillbirth or extensive congenital abnormalities of the fetus

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (3)

Rutgers The State University Of New Jersey

New Brunswick, New Jersey, 08854, United States

Location

Princeton Urogynecology

Princeton, New Jersey, 08540, United States

Location

Department of Gynecology and Obstetrics University Hospital

Pilsen, 30460, Czechia

Location

Study Officials

  • Vladimir Egorov, PhD

    Advanced Tactile Imaging, Inc.

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
CASE CONTROL
Time Perspective
RETROSPECTIVE
Sponsor Type
INDUSTRY
Responsible Party
SPONSOR

Study Record Dates

First Submitted

March 19, 2019

First Posted

March 21, 2019

Study Start

March 8, 2019

Primary Completion

January 10, 2020

Study Completion

February 25, 2020

Last Updated

April 13, 2020

Record last verified: 2020-04

Data Sharing

IPD Sharing
Will not share

Will be published.

Locations